Institution Providing IRB Review (CDC IRB) Sample Clauses

Institution Providing IRB Review (CDC IRB). Centers for Disease Control and Prevention (CDC) IRB Registration #: 00002724 Federalwide Assurance (FWA) #: FWA00001413 Registration expiration date: 12/17/2024 FWA expiration date: 12/02/2026 2 Institution Relying on CDC IRB (Relying Institution) Name of Relying Institution: IRB Registration #: IRB Registration Expiration Date: 3 Authorization The officials signing below agree that may rely on the CDC IRB for review under 21 CFR parts 50, 56 and 312 and for continuing oversight, where applicable, of the involvement of human subjects as described below: Title of IND: Reference ID: CDC IRB Relying Institution: Principal/Site Investigator: (name, phone, e-mail) IRB Office Contact: (name, phone, e-mail) Sponsor: Award number, if any: The review and oversight performed by the CDC IRB will meet the human subjects protection and IRB requirements of the FDA regulations cited above, as applicable. The Relying Institution remains responsible for ensuring compliance with the CDC IRB’s determinations and with the terms of its own IRB registration as applicable. This agreement must be kept on file at both institutions and must be provided to FDA upon request. Both parties agree to the following: This agreement becomes fully executed upon signatures of the relevant institution's signatory official or designee and remains in effect for as long as the review of the protocol by the reviewing IRB is required or until terminated under the following circumstances: ⁃ Both parties mutually agree to terminate. ⁃ Either party terminates its participation under this agreement; any such unilateral termination must be communicated by the terminating party to the other party thirty (30) business days prior to the effective date of termination. ⁃ The CDC IRB or Relying Institution's IRB registration is suspended, restricted, terminated, or expires; any such suspension, restriction, termination or expiration must be communicated between parties promptly and no later than 2 business days from occurrence.
AutoNDA by SimpleDocs

Related to Institution Providing IRB Review (CDC IRB)

  • Search, Enquiry, Investigation, Examination And Verification a. The Property is sold on an “as is where is basis” subject to all the necessary inspection, search (including but not limited to the status of title), enquiry (including but not limited to the terms of consent to transfer and/or assignment and outstanding charges), investigation, examination and verification of which the Purchaser is already advised to conduct prior to the auction and which the Purchaser warrants to the Assignee has been conducted by the Purchaser’s independent legal advisors at the time of execution of the Memorandum.

  • Institution and Investigator acknowledge that SPONSOR has no obligation to indemnify or be responsible for any loss, claim, cost (including reasonable attorney fees) or demand if and to the extent such losses, claims or demands arise from any injuries or damages resulting from Institution’s, Investigator’s or the Study Personnel’s negligence, breach of this Agreement, failure to adhere to the Protocol, failure to obtain signed informed consent forms, failure to follow Applicable Law, misuse of the Study Drug, unauthorized warranties, or willful misconduct. This indemnification obligation is without prejudice to the precedence of insurance coverage from compulsory clinical trial insurance. 12.3. Zdravotnické zařízení a zkoušející berou na vědomí, že ZADAVATEL nevyplatí žádné odškodnění ani není odpovědný za žádné ztráty, náklady, spory (včetně přiměřených nákladů na právní pomoc) či nároky v souvislosti s újmou či škodou, ke kterým došlo v důsledku nedbalosti na straně zdravotnického zařízení, zkoušejícího a/nebo členů týmu provádějícího klinické hodnocení a/nebo v důsledku toho, že zdravotnické zařízení, zkoušející a/nebo některý člen týmu provádějícího klinické hodnocení porušili ustanovení této smlouvy, porušili ustanovení protokolu, nenechali subjekt hodnocení podepsat informovaný souhlas, porušili ustanovení platných zákonů, chybným způsobem použili studijní léčivo ZADAVATELe, způsobili škodu úmyslným zaviněním a/nebo poskytli neoprávněné záruky. Touto povinností odškodnění není dotčeno přednostní pojistné krytí z povinného pojištění klinického hodnocení.

  • Office of Inspector General Investigative Findings Expert Review In accordance with Senate Bill 799, Acts 2021, 87th Leg., R.S., if Texas Government Code, Section 531.102(m-1)(2) is applicable to this Contract, Contractor affirms that it possesses the necessary occupational licenses and experience.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!